Histology, glycosaminoglycan level and cartilage stiffness in monoiodoacetate-induced osteoarthritis: comparative analysis with anterior cruciate ligament transection in rat model and human osteoarthritis by Naveen, S.V. et al.
Int. J. Med. Sci. 2014, Vol. 11 
 
 
http://www.medsci.org 
97 
International Journal of Medical Sciences 
2014; 11(1):97-105. doi: 10.7150/ijms.6964 
Research Paper 
Histology, Glycosaminoglycan Level and Cartilage 
Stiffness in Monoiodoacetate-Induced Osteoarthritis: 
Comparative Analysis with Anterior Cruciate Ligament 
Transection in Rat Model and Human Osteoarthritis 
Sangeetha Vasudevaraj Naveen1, Raja Elina Ahmad3, Wong Jia Hui1, Abdulrazzaq Mahmod Suhaeb1, 
Malliga Raman Murali, Rukmanikanthan Shanmugam1 and Tunku Kamarul1,2  
1. Tissue Engineering Group (TEG), National Orthopaedic Centre of Excellence in Research and Learning (NOCERAL), Department of 
Orthopaedic Surgery, Faculty of Medicine, University of Malaya, 50603 Lembah Pantai, Kuala Lumpur, Malaysia. 
2. Clinical Investigative Centre (CIC), University Malaya Medical Centre, Kuala Lumpur, Malaysia 
3. Department of Physiology, Faculty of Medicine, University of Malaya, 50603 Lembah Pantai, Kuala Lumpur, Malaysia.  
 Corresponding author: Raja Elina Ahmad, PhD, Department of Physiology, Faculty of Medicine, University of Malaya, 50603, Lembah Pantai, 
Kuala Lumpur, Malaysia. Tel: +603 79674922, Fax: +603 79674775; E-mail: elina@ummc.edu.my 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2013.06.21; Accepted: 2013.12.15; Published: 2013.12.21 
Abstract 
Monosodium -iodoacetate (MIA)-induced animal model of osteoarthritis (OA) is under-utilised 
despite having many inherent advantages. At present, there is lack of studies that directly compare 
the degenerative changes induced by MIA with the surgical osteoarthritis induction method and 
human osteoarthritis, which would further verify a greater use of this model. Therefore, we 
compared the histological, biochemical and biomechanical characteristics in rat model using MIA 
against the anterior cruciate ligament transection (ACLT) and human cartilage with clinically es-
tablished osteoarthritis. The right knees of Sprague-Dawley rats were subjected to either MIA or 
ACLT (n=18 in each group). Six rats were used as controls. Human cartilage samples were col-
lected and compared from patients clinically diagnosed with (n=7) and without osteoarthritis 
(n=3). Histological, biochemical (Glycosaminoglycans/total protein) and biomechanical (cartilage 
stiffness) evaluations were performed at the end of the 1st and 2nd week after OA induction. For 
human samples, evaluations were performed at the time of sampling. Histopathological changes in 
the MIA group were comparable to that observed in the ACLT group and human OA. The Mankin 
scores of the 3 groups were comparable (MIA: 11.5±1.0; ACLT: 10.1±1.1; human OA: 13.2±0.8). 
Comparable reduction in Glycosaminoglycan/total protein content in the intervention groups 
were observed (MIA: 7±0.6; ACLT: 6.6±0.5; human OA: 3.1±0.7). Cartilage stiffness score were 
24.2±15.3 Mpa for MIA, 25.3±4.8 for ACLT and 0.5±0.0 Mpa for human OA. The MIA model 
produces comparable degenerative changes to ACLT and human OA with the advantage of being 
rapid, minimally invasive and reproducible. Therefore, wider utilisation of MIA as animal transla-
tional OA model should perhaps be advocated. 
Key words: Animal model; joint; glycosaminoglycan; Mankin score; indentation test; stiffness; 
monosodium-iodoacetate. 
INTRODUCTION 
Osteoarthritis (OA), the clinical syndrome of 
joint pain and dysfunction, is a recognised major 
cause of disability, particularly in the aging popula-
tion (1). The increasing prevalence and absence of 
cure for the disease has resulted in OA being a sub-
stantial health economic burden for the nations. Thus, 
there is a pressing socioeconomic need for extensive 
improvements in the prevention and treatment of OA. 
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This has led to considerable research efforts being 
directed in the recent years to improve the under-
standing of this disease process. Whilst it would be 
more appropriate to study the pathogenesis of OA in 
human subjects, such pre-clinical studies may not 
have been widely conducted owing to a number of 
challenges. These include difficulty in obtaining se-
quential human joint tissues throughout the disease 
progression that is typically slow and variable, and, 
there is a lack of universally accepted tissue diagnos-
tic criteria or validated surrogate markers to monitor 
the disease progression and efficacy of treatment (2,3). 
In addition, human subjects are exposed to a multi-
tude of genetic and environmental factors that may 
influence the pathology of OA. These may act as 
confounding factors that could produce inconclusive 
evidence on the actual clinical efficacy of a particular 
therapy for OA. In light of this, the use of animal 
models particularly rats remained valuable and is a 
more practical approach to study OA. Various meth-
ods for inducing OA in rats exist at present (4). 
Among them, the anterior cruciate ligament transac-
tion (ACLT) model has been widely described and 
showed the appropriate histological and biochemical 
changes associated with OA progression (5). ACLT 
results in joint instability, and thus induces cartilage 
degeneration, subchondral bone sclerosis and osteo-
phyte formation, which mimics the pathological 
changes observed in human OA (6,7). Another com-
monly described OA induction method is the in-
tra-articular injection of monosodium-iodoacetate 
(MIA). This substance inhibits glyceralde-
hye-3-phosphate dehydrogenase activity in chondro-
cytes and thus results in cell death following the dis-
ruption of its cellular glycolysis process (8). The pro-
gressive loss of chondrocytes leads to changes in the 
histological and morphological features of articular 
cartilage, ultimately resulting in changes that closely 
resemble conditions seen in human OA (9-13). Despite 
being a convenient model (rapidity, ease of applica-
tion and consistency in the induction of cartilage 
damage), whether or not the MIA animal model ad-
equately represent human OA remains debatable. To 
date, it is still unclear whether the tissue characteris-
tics of the animal subjected to MIA injection are 
comparable to that of ACLT and human OA, since 
parallel comparisons between the three conditions 
have not yet been conducted. This study therefore 
aims to compare the cartilage tissue characteristics 
from the knee joint of Sprague-Dawley rats following 
chemical induction of OA (MIA) against the surgical 
method (i.e. ACLT) from a more comprehensive per-
spective, which include the histological, biochemical 
(GAG expression) and biomechanical (cartilage stiff-
ness) evaluation. In addition, to determine whether 
these models showed high similarities to human OA, 
the tissue characteristics in both animal models were 
compared to those of the human knee joints with 
clinically established OA.  
MATERIAL AND METHODS 
Animals 
Forty-two (N=42), 12-week old Sprague-Dawley 
(SD) rats weighing between 100 and 150 g, obtained 
from the Experimental Animal Centre of University 
Putra Malaysia, were used in this study. All animal 
experiments were conducted according to the guide-
lines for animal handling and welfare set by Univer-
sity of Malaya. Approval to conduct this study was 
granted by the University of Malaya ethics research 
review committee (OS/05/08/2009/WJH(R)). The 
rats were divided into three groups: Group 1 (n =18) 
underwent ACLT procedure; group 2 (n = 18) re-
ceived intra-articular injection of MIA; and group 3 
(n=6) were not subjected to any intervention and were 
used as controls. OA was induced by these methods 
only in the right knees of the animals. Within each 
intervention group, the rats were further grouped into 
three small subgroups consisting of three animals per 
subgroup (n = 3) for each of the 3 different analyses 
(histology, biochemical and biomechanical analysis). 
The animals were sacrificed using a lethal dose of 
intraperitoneal ketamine on the 1st and 2nd week after 
the ACLT procedure and MIA injection to observe the 
progression of OA in the animals. Thus, nine rats 
(n=9) per intervention group were sacrificed at each 
time point for data comparison. All 6 rats in the con-
trol group were sacrificed immediately, since it is ex-
pected that in the normal knees, there would not be 
any apparent change in the cartilage within the short 
time frame of testing. The normal knee samples har-
vested for the laboratory analyses represent the con-
trol data for both week 1 and 2. In all animals, the 
whole knee cartilage was resected and subjected to 
histological, biochemical and biomechanical exami-
nations.  
Human tissue samples 
Acquisition of tissues samples from patients was 
approved by the University of Malaya Medical Centre 
Ethics committee (Ethics ref. No. 832.12). Knee spec-
imens from humans were collected from 7 patients 
diagnosed clinically with OA who underwent total 
knee replacement, and 3 patients without OA who 
underwent knee surgery e.g. ACL reconstruction or 
trauma (normal tissue). Clinical diagnosis of OA was 
done based on the clinical history and examination 
performed by a senior orthopaedic surgeon. This was 
further confirmed by the gross morphological chang-
es of the tissues seen during surgery, which include 
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very thin cartilage, exposed bone, visible osteophytes 
and change in cartilage colour from the shiny white 
usually seen in normal cartilage to a yellowish col-
oured tissue. In addition, OA in these patients were 
also diagnosed based on radiological criteria, which 
include narrow joint spaces, sub-chondrosis and os-
teophytes formation. As for the group representing 
the normal cartilage, the patients (n =3) have never 
been clinically diagnosed with OA nor had previous 
history of any joint diseases. The absence of OA in this 
group was further confirmed by radiological investi-
gation, and furthermore, the cartilage appeared nor-
mal and deemed to be intact during the operation. 
The cartilage was taken from young patients and from 
non-weight bearing sites, which would not be ex-
pected to have undergone any OA changes. These 
patients were trauma patients who were otherwise 
healthy and had uneventful past medical history. 
Written informed consent was obtained from each 
patient prior to the surgery.  
Surgical induction of OA by anterior cruciate 
ligament transection 
Animals were anesthetized using Ketamine hy-
drochloride (50 mg/ml for injection USP, Rotex-
medica, Germany) and Xylazine hydrochloride (Ilium 
Xylazil-20 20mg/ml for injection, Troy laboratories 
Pty Ltd.). The dose of the anaesthetic agents was 
measured and delivered according to the body weight 
of the rats. After sterilisation of the animal’s body 
area, a para-median skin incision was made via the 
medial para-patellar approach and the patella was 
retracted laterally. Using micro-surgical instruments, 
the anterior cruciate ligament-tendon joint was iden-
tified, transected and was subsequently washed with 
normal saline. The surgical wound was then closed in 
layers. 
 Chemical induction of OA using 
Monosodium-iodoacetate injection 
The rats were anesthetized using Ketamine hy-
drochloride (50 mg/ml for injection, USP, Rotex-
medica, Germany) and Xylazine hydrochloride (Ilium 
Xylazil-20 20mg/ml for injection, Troy laboratories 
PTY limited) and placed in the supine position. The 
intra-patellar tendon was identified and a single in-
tra-articular injection of 2 mg of Monosodi-
um-iodoacetate (MIA) (Crystal Powder M=185.96 
g/mol, Germany, Sigma) in a total volume of 25 µl 
was injected into the right knee.  
Histological evaluation 
Animals were euthanized and the knee joints 
were dissected to obtain the distal femur. Samples 
were decalcified in 10% formic acid for 11 to 14 days. 
The distal femur was cut with an aim to obtain the 
center of the medial condyle (i.e. the mechanical 
weight bearing area) for histology. Samples were de-
hydrated in ethanol series immersion and embedded 
in paraffin. For each block, a minimum of ten slides 
with at least three samples of tissue per slide was ob-
tained to minimise sampling errors. Prior to staining, 
the paraffin was removed by immersing the slides for 
two minutes in xylene and ethanol solutions. The 
slides were divided equally for haematoxylin-eosin 
(cellular architecture) and Safranin-O-fast green 
staining (proteoglycan contents of matrix). Histologi-
cal assessment based on the Mankin scoring system 
was carried out by two independent observers who 
were blinded to the study groups. Using this 
well-established method, the tissues were given 
scores ranging from 0-14, with 0 corresponding to a 
normal joint, and 14 for maximally degenerated joint 
(14). 
Biochemical analysis  
Protein and glycosaminoglycan (GAGs) levels 
were determined using Bio-Rad DC protein assay kit 
(Bio-Rad Laboratories; USA) and Blyscan sulfated 
Glycosaminoglycan assay kit (Biocolor Ltd., UK) ac-
cording to the manufacturer’s protocols. The levels of 
GAG and total protein were measured in the dissect-
ed whole section of the knee i.e. the total surface of the 
femur and tibia that has not undergone any pro-
cessing procedure. Spectrophotometric absorbance 
measurement for protein was obtained at 750 nm 
wavelength, while that of GAG was obtained at 656 
nm wavelength. GAG content was normalized to the 
protein contents and expressed in the unit of µg 
GAG/mg protein. 
Biomechanical evaluation 
Biomechanical testing was performed at week 2 
post-intervention. The cartilage stiffness was evalu-
ated by microindentation test using an Instron mi-
crotester 5848 attached with a 50 N load cell. The res-
olution of testing was 0.01 N load and 0.01 mm dis-
placement. The test was performed on the medial 
femoral condyle and was standardized to a localized 
area. The harvested femur (fresh specimen) was se-
cured onto a custom made jig such that the area of 
interest was positioned orthogonal to the indenter. 
The cartilage was kept hydrated using phosphate 
buffered saline (PBS). A flat tip conical indenter with a 
tip diameter of 256 µm was placed in contact with the 
cartilage that was preloaded to 0.01 N. The preload 
was maintained for 10 minutes until equilibrium was 
achieved. Ramp load of 0.04 N at a speed of 10 
mm/min was used. The initial linear portion of the 
load displacement curve was used to calculate the 
stiffness of the cartilage. The biomechanical test was 
performed in 3 replicates covering 6 different areas, 
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and the average value of the data was subsequently 
used in the statistical analysis.  
Statistical analysis 
Results were expressed as mean ± standard de-
viation for each parameter examined. The data were 
analysed using non-parametric test (Mann-Whitney 
U). Correlations between the histological, biochemical 
and biomechanical parameters were determined by 
Spearman’s correlation and linear regression analyses. 
Correlation values were interpreted according to the 
guidelines of Landis and Koch: 0.00 as poor, 0.00–0.20 
as slight, 0.21–0.40 as fair, 0.41–0.60 as moderate, 
0.61–0.80 as substantial, and 0.81–1.00 as almost per-
fect (15). A p value of <0.05 was considered statisti-
cally significant. All analyses were conducted using 
the statistical software SPSS version 17.0. 
RESULTS 
Histology 
Cartilage degeneration and abrasion were evi-
dent in all OA specimens originating from both ani-
mal and human tissues. In the rats, cartilage tissues 
from the normal knee (from the control group) 
showed normal histological appearance and proteo-
glycan content (Fig. 1A), whereas those subjected to 
ACLT and MIA injection showed varying degrees of 
joint degeneration at week 2 post-intervention, which 
were comparable to each other (Fig. 1B and 1C). 
The Mankin scores throughout the duration of 
the experiment are summarised in figure 2. The con-
trol group has the lowest score (0), reflecting good 
cartilage tissue quality. The expected characteristics of 
a normal cartilage tissue including a preserved 
structural integrity of the continuous articular surface, 
intact tidemark, normal cellular distribution and ori-
entation, and normal staining with Safranin-O were 
observed in this group. In contrast, the MIA group 
had a mean score of 6.0±0.9 in the 1st week and 
11.5±1.0 at the end of week 2 (Fig. 2A), and the histo-
pathological changes were similar to that observed in 
the ACLT group (ACLT at week 1 = 7.2 ±1.2 and week 
2 = 10.1±1.1). The Mankin score for both intervention 
groups at week 2 post-intervention appeared to be 
comparable to that of the human OA condition 
(13.2±0.8) (p>0.05) (Fig.2B).  
 
Figure 1: Sagittal section through the medial femoral condyles of rat (10X).(A) Normal articular cartilage structures showing smooth articular surface, normal 
chondrocytes with columnar orientation, intact tide mark and subchondral bone (Mankin score - 0). (B) At 2 weeks post-ACLT, a confined area of cartilage de-
struction was observed as reflected by the irregularity of the articular surface and moderately reduced chondrocyte numbers. The tidemark remained visible and the 
subcondral bone remained intact (Mankin score – 10). (C) At 2 weeks post-MIA injection, more destructive changes over the femoral condyle was observed, with the 
loss of articular cartilage integrity, moderate to severe reduction in chondrocytes that appear to be necrotic and largely dispersed. The tide mark was not clearly 
visible (Mankin score -11).  
 
Figure 2: A) The use of MIA causes increased cartilage degeneration as reflected by the increase in Mankin scores overtime, which is comparable to that of ACLT 
(p>0.05). B) The histological scores for both animal models of OA at week 2 post-intervention were comparable to that of human OA (p>0.05).  
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Biochemical Analysis 
Fig 3A and 3B represents the GAG/total protein 
of tibia and femur for MIA and ACLT groups, respec-
tively. The results show that the GAG/total protein 
was significantly lower in tibia and femur in both 
intervention groups compared to the control group 
(p<0.05); however, in the intervention groups, the 
GAG/protein content was significantly lower in the 
femur than in tibia at both time points (p<0.05) (table 
1 and 2). No significant difference was observed be-
tween week 1 and week 2 in the ACLT group, which 
indicates that ACLT has reached its maximal damag-
ing effect as early as week 1 and this persisted till 
week 2. However, in the MIA group, the GAG/total 
protein content was significantly lower in week 2 
compared to week1, indicating that considerable 
damage to the cartilage may have occurred at a rela-
tively slower pace when OA is induced by this 
method. However, no significant difference was ob-
served between the MIA and ACLT group at week 2, 
indicating similar extent of damage in both groups at 
the end of week 2. Nevertheless, the animal tissues in 
both intervention groups had significantly higher 
GAG/total protein level than that in the human OA 
tissue samples. In the human OA samples, the 
GAG/total protein level was significantly lower in the 
OA samples (3.1±0.7) as compared to the normal 
knees (13.5±2.5), indicating a relatively lower extra-
cellular matrix components in the degenerated carti-
lage tissues (P<0.05) (Fig.3C). 
 
Table 1: GAG/total protein concentration in Tibia 
Week Group Mean ± Standard 
Deviation 
Comparison between 
groups (P values) 
Normal ACLT 
Week 1 ACLT 14.6±1.3 0.002* NIL 
MIA 16.8±1.5 0.02* 0.02* 
Normal 25.6±4.8 NIL 0.002* 
Week 2 ACLT 12.9±1.1 0.002* NIL 
MIA 10.9±0.9 0.002* 0.02* 
Normal 25.6±4.8 NIL 0.002* 
*-Significant, P<0.05. 
Table 2: GAG/total protein concentration in Femur 
Week Group Mean ± Standard 
Deviation 
Comparison between 
groups (P values) 
Normal ACLT 
Week 1 
 
 
ACLT 6.8±0.6 0.002* NIL 
MIA 12.1±1.1 0.002* 0.002* 
Normal 22.9±4.6 NIL 0.002* 
Week 2 ACLT 6.6±0.5 0.002* NIL 
MIA 7.1±0.6 0.002* 0.394 
Normal 22.9±4.6 NIL 0.002* 
*-Significant, P<0.05. 
 
 
Figure 3: Compared to the normal tissues, GAG/total protein levels were lower in both intervention groups at the tibia (A) and femur (B). Although at week 1, the 
GAG/total protein levels were higher in the MIA group compared to ACLT at both tibia and femur, by week 2, the concentrations had dropped to a level comparable 
to that in the ACLT group, specifically in femur. In human samples, significant reduction of GAG/total protein was observed in the OA samples compared to normal 
tissue (C) (* indicates significance p<0.05).  
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Figure 4: Cartilage stiffness of normal, MIA and ACLT rats (A) and human tissues (B) showed significantly lower cartilage stiffness scores. No significant difference 
in the cartilage stiffness between MIA and ACLT (p>0.05). 
 
Biomechanical evaluation 
Since our histology results showed more de-
structive changes at week 2 compared to week 1 (data 
not shown), the biomechanical evaluation was per-
formed on the samples only at week 2. Figure 4A and 
4B represents the cartilage stiffness for rat and human, 
respectively. The intervention groups had signifi-
cantly lower cartilage stiffness scores (MIA = 24.2 ± 
15.3 Mpa and ACLT = 25.3 ± 4.8 Mpa) as compared to 
that in the normal knees (118.43 ± 25.2 MPa) (p<0.05). 
However, no significant difference was observed 
between ACLT and MIA group. Analysis of the hu-
man tissue samples revealed lower cartilage stiffness 
score in the human OA group (0.5 ± 0.0 MPa) as 
compared to that of the normal cartilage (control 
group) (1.1 ± 0.5 MPa; p < 0.05). 
Correlation Analysis 
The results of the correlation analysis between 
the various parameters (histology, GAG/total protein 
and biomechanical) assessed in the rat tissue samples 
are shown in figure 5. Considering that in week 1, the 
GAG/total protein content in the MIA group was 
significantly higher than in week 2 suggesting that the 
damage was still progressing, whereas in week 2, the 
levels were much lower and comparable to that in the 
ACLT group suggesting that the maximal damaging 
effect may have been reached in both groups at this 
time point, hence, only data from week 2 (ACLT and 
MIA) were included in the correlation analysis to 
avoid selective biasness. There was a strong correla-
tion between GAG/total protein level and the carti-
lage stiffness (R2 = 0.88, (p<0.05); Fig. 5A), such that 
for every 1 unit of GAG/total protein loss, the stiff-
ness reduces by 0.26 ± 0.03 MPa. The GAG/total pro-
tein level was also perfectly correlated with the his-
tological score (Mankin) (R2 = 0.92, p<0.05; Fig. 5B) to 
the extent that the loss of 1 unit of GAG/TP is associ-
ated with 1.2 ± 0.1 unit reduction in the Mankin score. 
No significant correlation was observed between the 
cartilage stiffness and histological scores (p>0.05) (Fig 
5C).  
DISCUSSION  
The present study demonstrates that chemical 
induction of osteoarthritis by intra-articular injection 
of Monosodium Iodoacetate (MIA) in rat model re-
sults in cartilage degenerative changes that are com-
parable to that produced by the anterior cruciate 
ligament transection method (ACLT) and more im-
portantly to that of human with clinically established 
OA. This include structural changes such as lack of 
surface regularities, cartilaginous matrix collapse, 
cartilage fibrillation as well as functional change such 
as reduction in the compressive stiffness of the artic-
ular cartilage, which will ultimately affect the ability 
of the tissue to withstand the effect of load-bearing 
activities.  
Previous isolated studies have indicated that in-
tra-articular injection of MIA does not create OA like 
ACLT or other surgical methods (16,4). Nevertheless, 
this issue remains debatable and that contrasting re-
ports have also been observed in many literatures 
(17-19). In this study, we have detected apparent de-
generative changes in the articular cartilage of the 
MIA-induced animals that are comparable to that of 
ACLT. However, there is a difference in how rapidly 
the development of OA occurs. It is postulated that 
this time-dependent progression may be due to the 
different mode of action in the knee joints (10). Earlier 
studies have reported that MIA has inhibitory effect 
on the activity of glyceraldehydes-3 phosphate dehy-
drogenase in chondrocytes resulting in disruption of 
glycolysis, hydration of the extracellular matrix, in-
creased extractability as well as reduced quantity and 
synthesis of proteoglycans, and eventually leads to 
cell death. Subsequently, the histological and bio-
chemical changes occurred in the articular cartilage of 
the knee joint bears close resemblance to human OA 
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(20-22). The slow chronological progression of OA 
demonstrated in this study is consistent to that re-
ported by Guzman (23). In contrast, OA in the ACLT 
model that is the result of mechanical delamination of 
cartilage causes immediate damage to this tissue, 
which results in acute inflammatory response. This in 
turn produces extensive structural changes within a 
short period (8,23,24). Furthermore, since ACLT is an 
instability- or biomechanically-induced model, factors 
such as cage dimensions and flooring could play a 
role in the development of the disease as they influ-
ence the animal’s activity on the affected limb (25). In 
the present study, the GAG/total protein level was 
significantly lower in ACLT group compared to MIA 
at week-1 post OA induction but reached similar level 
2 weeks after the induction of OA, indicating that 
ACLT induces destruction of the extracellular matrix 
of the articular cartilage at a faster rate compared to 
MIA.  
 
 
Figure 5: Substantial correlation was observed between GAG/Total protein with two other parameters i.e. cartilage stiffness (A) and histological scores (B). No 
significant correlation was observed between the histological score and biomechanical testing (C). 
 
It is a well-known fact that, in the highly orga-
nized extracellular matrix of articular cartilage, water 
occupies the intra-molecular and inter-molecular 
space within a network of collagen fibrils (15% to 22% 
by wet weight) and proteoglycan aggregates (4% to 
7% by wet weight) (26,27). Studies have demonstrated 
that along with other factors, proteoglycan content, 
fixed charge density and molecular organization of 
the matrix determines the pore size of the tissue, 
thereby regulating the permeability of the interstitial 
fluid flow (28,29). The levels of GAG/total protein 
content were measured in this study to reflect the 
biochemical changes related to the degenerative pro-
cess outlined above. Compared to the normal tissue, 
both ACLT and MIA osteoarthritis rat models showed 
a marked difference in the altered structure (histo-
pathology) and GAG content 2 weeks post OA induc-
tion. Similarly, the human cartilage affected by OA 
also has markedly reduced GAG/total protein con-
tent compared to its healthy counterparts. Higher 
heterogeneity of the disease in the human tissue 
samples may explain the observation that the 
GAG/total protein content in the animal tissues sub-
jected to both OA induction methods remained rela-
tively higher than that in the human OA tissue sam-
ples. It was also observed that the differences in the 
GAG/total protein level were more striking in the 
femur rather than in the tibia. This may be due to the 
fact that when a knee undergoes flexion-extension, a 
series of rolling, sliding and gliding motion is ob-
served between the joint surfaces of the proximal tibia 
and distal femur (30-33). Because the surface area of 
the femoral condyle is larger than the tibial plateau, 
the shearing effect is more likely to be experienced on 
this surface area, being distributed throughout the 
articulating surfaces. This results in more articular 
cartilage being damaged (34-36). Furthermore, the 
tibial plateau is covered by the meniscus, which will 
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have a protective effect against shearing and loading 
mechanical forces. Thus, the cartilage within the tibial 
surface is less likely to be affected (33,37) . It is also 
worth noting that after undergoing ACLT transection, 
the slide and rolling motion that is observed in normal 
knee kinematics will now be replaced with gliding 
motions (38,39). This will result in increased articular 
surface wear and tear on the femoral side as the result 
of excessive shearing forces being applied. This also 
leads to increased delamination of the femoral carti-
lage, hence the increased loss of cartilage from the 
femoral surface. 
 To increase the dimension of assessment of the 
OA changes in the affected tissues, we have incorpo-
rated the biomechanical testing to evaluate the tensile 
strength of the cartilage in response to compression 
load. Our findings of reduced cartilage stiffness in 
both animal OA models and human OA appear to be 
consistent with the findings of others (40). The sim-
ultaneous decrease in the GAG content may affect the 
stiffness and the visco-elastic property of the cartilage. 
Given that the tensile stiffness and strength of carti-
lage depend on the organization of the collagen net-
work, denaturing the collagen network subsequently 
leads to the development of OA (41). Furthermore, 
recent studies using delayed Gadolinium-Enhanced 
Magnetic Resonance Imaging of Cartilage (dGEMRIC) 
have also shown a high correlation between GAG 
distribution and biomechanical properties of cartilage 
(42). Similarly, we have also demonstrated a positive 
correlation between GAG contents with cartilage 
stiffness in this study. Several studies suggest that a 
simultaneous determination of the mechanical prop-
erties and GAG content of articular cartilage (espe-
cially if the GAG content is determined at the site of 
indentation) may provide valuable information to-
ward understanding the aetiology of OA in articular 
cartilage, especially during the early stages of the 
disease process (43-45).  
Considering that the degenerative changes in-
duced by MIA is similar to that of ACLT and human 
OA, together with its additional advantage of being 
only minimally invasive, reproducible and relatively 
easy to conduct, MIA can be considered to be a more 
practical alternative than ACLT as a translational 
animal model of OA. The onset, progression and se-
verity of OA can be easily controlled in this model by 
changing the dose of MIA. Guingamp et al. previ-
ously showed that the severity of cartilage degrada-
tion depends on the dosage of MIA injected into the 
knee joint (21). A recent preliminary study by Mohan 
et al indicated that a higher dose of MIA (2 mg) pro-
duced tissue characteristics consistent with severe 
human OA at 2 weeks post-injection, an observation 
supported by the present study (17). At a lower dose, 
the degenerative changes such as loss of tibial articu-
lar cartilage, exposure of subchondral bone and os-
teophytes formation were only apparent at 10 weeks 
post-injection. MIA model also has an additional ad-
vantage of being a suitable model for investigating 
chronic pain, particularly that associated with OA 
(18,19). The introduction of MIA to the knee joint re-
sults in acute inflammation, leading to the release of 
pain mediators such as prostaglandins, bradykinin 
and substance P in the local area. Although the in-
flammatory response to the MIA injection has shown 
to have been largely resolved by 7 days post-injection, 
it may have a residual effect of sensitising the pe-
ripheral receptors, leading to a C-fibre mediated de-
crease in the threshold of action potential generation 
and an increase in the afferent nerve transmission to 
the spinal cord (46). The extended activation of the 
nociceptive pathways may contribute to the devel-
opment of chronic pain. Thus, the MIA injection rat 
OA model can potentially be used to predict the effi-
cacy of anti-nociceptive agents in OA. 
Despite the detailed preparation and robust de-
sign of this study, several limitations were noted. The 
main limitation to the present study is in the few 
numbers of rats used in each group i.e. 18 rats per 
group and 3 rats at each time point and parameter of 
evaluation. While this hampers a more convincing 
conclusion to be drawn from this study, it does pro-
vide preliminary data which may justify larger scale 
studies to be conducted. The use of more objective 
and sophisticated outcome measures, which may in-
clude analysis of cartilage gene expression such as 
COMP, may have extended the dimension of assess-
ment of the degenerative effect of MIA and ACLT on 
the animal tissues. Despite being preliminary in na-
ture, we believe that the present study offers valuable 
data that could promote further use of the MIA injec-
tion rat model as translational animal model of OA in 
future studies.  
In conclusion, the findings of this study demon-
strate that MIA injection in the rat knee joint effec-
tively induces degenerative changes in the tissues that 
were comparable to that of the ACLT method and 
human knee with clinically established OA. In view of 
its minimal invasiveness and greater convenience of 
the procedure, increased use of MIA injection as 
translational animal model of OA should be consid-
ered.  
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